Live
ScienceWolves are reconquering Europe. Can people learn to live with them?Clinical OMICsPakistan’s Massive Genetic Database Reveals Millions of Unique VariantsClinical OMICsFirst Novel Antifungal for Aspergillus in 20 Years Succeeds in Phase IIIBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-June 18, 2026Endpoints NewsTreasury weighs screening investments in China biotechBioPharma DivecAMPfield lands $180M to build gut disease drugEndpoints NewsNovo Nordisk expands in China and Czech; Cellares boosts Series D by $50MBioPharma DiveBiogen adds more immune drugs in $1B buyout of secretive startup RaytheraPromega BlogWhat Happens When You Delay an Ebola Vaccine Booster by 18 Months?FierceBiotechcAMPfield harvests $180M series A to advance oral IBD drug licensed from NewsoaraEndpoints NewsIRA's Medicare out-of-pocket cap increased access to drugs, study finds
Illumina Jan 23, 2026

$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance Singapore

$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leadi...

Body unavailable. Use the original source.